Fount of Information

ACROBiosystems社 Tau-targeted Therapies for Alzheimer's Disease



Products Support Insights Resources


In the search for effective Alzheimer's disease (AD) treatments, tau-targeted therapies includes reducing tau expression, targeting tau protein modifications, inhibiting tau aggregation, stabilizing microtubules, and employing active and passive immunotherapies. These therapies aim to interrupt the pathological processes triggered by tau protein, ultimately striving to slow or halt the progression of AD.



Tau-related therapeutic targets


To support research into the diagnosis and treatment of AD, ACROBiosystems provides you with diverse Tau recombinant proteins and Tau-441 Pre-formed Fibrils.


Verification Data




Immobilized Human Tau-441 (P301L), His Tag (Cat. No. TAU-H5144) at 5 μg/mL (100 μL/well) can bind Tau Monoclonal Antibody with a linear range of 0.5-8 ng/mL (QC tested).



Bioactivity-ThT Assay


Thioflavin T emission curves show increased fluorescence (correlated to tau aggregation) over time when tau K18 monomers are combined with Human Tau-441 K18 Pre-formed Fibrils Protein, His Tag (Cat. No. TAU-H5146) (Routinely tested).




Discover More Products


Tau_5.jpg Tau_6.jpg

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。